These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 2676892

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Can early thromboembolic complications after valve replacement be avoided?
    Kure HH, Schüller H, Thulin L, Olin C.
    Z Kardiol; 1986; 75 Suppl 2():302-4. PubMed ID: 3727707
    [No Abstract] [Full Text] [Related]

  • 4. Do all patients with mechanical heart valve prostheses need anticoagulant therapy?
    Dale J, Nitter-Hauge S.
    Z Kardiol; 1986; 75 Suppl 2():332-7. PubMed ID: 3727714
    [No Abstract] [Full Text] [Related]

  • 5. Thromboembolic events in prosthetic valve recipients: what is the safe level of anticoagulation?
    Acar J.
    J Heart Valve Dis; 1993 Jul; 2(4):395-7. PubMed ID: 8269141
    [No Abstract] [Full Text] [Related]

  • 6. Guidelines for prevention of thromboembolic events in valvular heart disease. Ad Hoc Committee of the Working Group on Valvular Heart Disease, European Society of Cardiology.
    Gohlke-Bärwolf C, Acar J, Burckhardt D, Oakley C, Butchart E, Krayenbühl P, Hall R, Bodnar E, Krzeminska-Pakula M, Delahaye JP.
    J Heart Valve Dis; 1993 Jul; 2(4):398-410. PubMed ID: 8269142
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prevention of thromboembolism with ticlopidine shortly after valve repair or replacement with a bioprosthesis.
    Aramendi JL, Agredo J, Llorente A, Larrarte C, Pijoan J.
    J Heart Valve Dis; 1998 Nov; 7(6):610-4. PubMed ID: 9870193
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Prevention of hemorrhagic and thromboembolic complications in heart valve prosthesis].
    Pospelova EP, Stepanian EP, Shchurkalina TKh, Movsesian RA.
    Grudn Khir; 1971 Nov; 13(1):49-51. PubMed ID: 5577527
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Low profile bioprostheses for mitral valve replacement.
    Romano M, Sigal R, Lorente P, Piwnica A.
    Z Kardiol; 1986 Nov; 75 Suppl 2():305-7. PubMed ID: 3727708
    [No Abstract] [Full Text] [Related]

  • 14. Anticoagulation is necessary in patients with atrial fibrillation after mitral valve replacement with bioprostheses.
    Rothlin ME.
    Z Kardiol; 1986 Nov; 75 Suppl 2():317-20. PubMed ID: 3727710
    [No Abstract] [Full Text] [Related]

  • 15. Triflusal versus oral anticoagulation for primary prevention of thromboembolism after bioprosthetic valve replacement (trac): prospective, randomized, co-operative trial.
    Aramendi JI, Mestres CA, Martinez-León J, Campos V, Muñoz G, Navas C.
    Eur J Cardiothorac Surg; 2005 May; 27(5):854-60. PubMed ID: 15848326
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.